期刊文献+

压力容积导管系统评价卒中易感性自发性高血压大鼠左心室功能的意义 被引量:2

Assessment of Left Ventricular Function in Stroke-Prone Spontaneously Hypertensive Rats by Pressure-Volume Conductance Catheter System
下载PDF
导出
摘要 目的采用压力容积导管研究慢性压力超负荷对高血压大鼠左心室(LV)血流动力学的影响。方法10只6月龄雄性卒中易感性自发性高血压大鼠(SHR-SPs)和10只同月龄雄性 Wistar-Kyoto(WKY)大鼠分别作为高血压组和对照组。对两组大鼠行在体 LV 血流动力学检测,大鼠麻醉后经右颈总动脉向 LV 内插入2F Millar 压力容积导管(SPR-838),记录大鼠稳定状态和改变心脏前负荷时的压力-容积(P-V)变化。结果与 WKY 大鼠比较,SHR-SPs LV 收缩末压、LV 收缩末容积和室内压最大上升速率(+dP/dt_(max))均增高,而射血分数、每搏输出量和心排血量均出现降低(P<0.05)。在压力负荷的影响下,SHR-SPs LV 收缩末压力容积曲线的斜率代偿性增高(P<0.05)。SHR-SPs LV 舒张末压、LV 舒张末容积和 LV 压力衰退的时间常数均高于 WKY 大鼠(P<0.05),而室内压最大下降速率(-dP/dt_(min))低于 WKY 大鼠(P<0.05)。与 WKY 大鼠比较,SHR-SPs 在体 LV P-V 曲线出现了明显的右移。结论 SHR-SPs 发生了 LV 舒张功能障碍及收缩功能减低,并在此基础上伴有一定程度的 LV 扩张。压力容积导管能够客观准确地评价大鼠的心功能。 Objective Using pressure-volume conductance catheter system to investigate the effect of chronic pressure-overload on left ventricular (LV) hemodynamics in hypertensive rats. Methods Six-month-old male stroke-prone spontaneously hypertensive rats (SHR-SPs, n= 10) and age-matched male Wistar-Kyoto (WKY) rats (n=10) were used. The animals were anaesthetized and a 2F Millar pressure-volume conductance catheter (SPR- 838) was inserted through right carotid artery into LV to measure pressure-volume (P-V) relationship. Results We found that left ventricular end-systolic pressure, left ventricular end-systolic volume and +dP/dtmax were all remarkablely higher in SHR-SPs than those in WKY rats (P〈0.05). Compared with WKY rats, ejection fraction, stroke volume and cardiac output were decreased in SHR-SPs ( P〈0.05). The slope of left ventricular end systolic pressure-volume relationship was greatly elevated in SHR-SPs. The constant of isovolumeric relaxation (Tau) was prolonged in SHR-SPs (P〈0.05) and left ventricular end-diastolic pressure and left ventricular end-diastolic volume were significantly increased in SHR-SPs than in WKY rats (P〈0.05). In addition, -dP/dtmin. was decreased in SHR-SPs (P〈0.05). The in vivo P-V loop curve was notably rightward shifted in SHR-SPs. Conclusion These results show that pressure-overload could induce LV diastolic dysfunction, deterioration of systolic performance and partial LV dilation. The pressure-volume conductance catheter system is an useful tool for objective and accurate assessment of cardiac function in rats.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2008年第8期737-741,共5页 Chinese Journal of Hypertension
基金 武警总部科研基金(WY2005-5)
关键词 高血压 左心室重塑 左心室功能 Hypertension Left ventricular remodeling Left ventricular function
  • 相关文献

参考文献14

  • 1[1]Pacher P,Mabley JO,Liaudet L,et at.Left ventricular pressurevolume relationship in a rat model of advanced aging-associated heart failure[J].Am J Physiol Heart Circ Physiol,2004,287:H2132-2137.
  • 2[2]Nielsen JM,Kristiansen SB,Ringgaard S,et al.Left ventricular volume measurement in mice by conductance catheter:evaluation and optimization of calibration[J].Am J Physiol Heart Circ Physiol,2007,293:H534-540.
  • 3[3]Yang B,L.arson DF,Watson R.Age-related left ventrieular function in the mouse:analysis based on in vivo pressure-volume relationships[J].Am J Physiol,1999,277:H1906-1913.
  • 4[4]Lips DJ,van der Nagel T,Steendijk P,et al.Left ventrieular pressure-volume measurements in mice.,comparison of closedchest versus open-chest approach[J].Basic Res Cardiol,2004,99:351-359.
  • 5[5]Connelly KA,Prior DL,Kelly DJ,et al.Load-sensitive measures may overestimate global systolic function in the presence of left ventricular hypertrophy:a comparison with load-insensitive measures[J].Am J Physiol Heart Circ Physiol,2006,290:H1699-1705.
  • 6[6]Costandi PN,Frank LR,McCulloch AD,et al.Role of diastolic properties in the transition to failure in a mouse model of the cardiac dilatation[J].Am J Physiol Heart Circ Physiol,2006,291:H2971-2979.
  • 7[7]Murphy AM,Kogler H,Georgakopoulos D,et al.Transgenic mouse model of stunned myocardium[J].Science,2000,287:488-491.
  • 8[8]Pacher P,Liaudet L,Bai P,et al.Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubiein-induced cardiac dysfunction[J].Circulation,2003,107:896-904.
  • 9[9]Joho S,Ishizaka S,Sievers R,et al.Left ventricular pressurevolume relationship in conscious mice[J].Am J Physiol Heart Cire Physiol,2007,292:H369-377.
  • 10[10]Maurer MS,King DL,E1-Khoury Rumbarger L,et al.Left heart failure with a normal ejection fraction:identification of different pathophysiologic mechanisms[J].J Card Fail,2005,11:177-187.

同被引文献22

  • 1王学惠,卓小桢,倪雅娟,卢群,龚敏,王亭忠,马爱群.Neuregulin-1β对容量超负荷心衰大鼠的治疗作用[J].西安交通大学学报(医学版),2012,33(2):194-198. 被引量:6
  • 2曹雅旻,胡大一,王宏宇,吴彦.我国基层医院慢性心力衰竭药物治疗现状调查[J].中华内科杂志,2006,45(11):907-909. 被引量:72
  • 3Pacher P, Mabley JG, Liaudet L, et al. Left ventricular pressure- volume relationship in a rat model of advanced aging-associated heart failure [ J ]. Am J Physial Heart Circ Physiol, 2004, 287(5) : H2132 - H2137.
  • 4Conrad CH, Brooks WW, Robinson KG, et al. Impaired myocar- dial function in spontaneously hypertensive rats with heart failure[J]. Am J Physiol, 1991, 260 (1 Pt 2): H136- H145.
  • 5Lips DJ, van der Nagel T, Steendijk P, et al. Left ventricular pressure-volume measurements in mice : comparison of closed-chest versus open-chest approach [ J ]. Basic Res Cardiol, 2004, 99(5) : 351 -359.
  • 6Pacher P, Liaudet L, Bai P, et al. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the develop- ment of doxorubicin-induced cardiac dysfunction[ J]. Circulation, 2003, 107(6): 896-904.
  • 7Joho S, Ishizaka S, Sievers R, et al. Left ventricular pressure- volume relationship in conscious mice [ J ]. Am J Physiol Heart Circ Physiol, 2007, 292( 1 ) : H369 - H377.
  • 8Maurer MS, King DL, El-Khour/ Rumbarger L, et al. Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms [ J ]. J Card Fail, 2005, 11 ( 3 ) : 177 - 187.
  • 9Maurer MS, Kronzon I, Burkhoff D. Ventricular pump function in heart failure with normal ejection fraction : insights from pressure- volume measurements[ J ]. Prog Cardiovase Dis, 2006, 49 (3) : 182 - 195.
  • 10Nauck M, Frid A, Herrnansen K, et al. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes) -2 study [ Jl. Diabetes Care, 2009, 32( 1 ) : 84 -90.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部